000 | 01988 a2200613 4500 | ||
---|---|---|---|
005 | 20250516034000.0 | ||
264 | 0 | _c20111209 | |
008 | 201112s 0 0 eng d | ||
022 | _a1552-454X | ||
024 | 7 |
_a10.1177/1087057111405379 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, Jonathan A | |
245 | 0 | 0 |
_aOpen innovation for phenotypic drug discovery: The PD2 assay panel. _h[electronic resource] |
260 |
_bJournal of biomolecular screening _cJul 2011 |
||
300 |
_a588-602 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins E _xmetabolism |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aNocodazole _xpharmacology |
650 | 0 | 4 |
_aOsteoblasts _xcytology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTubulin Modulators _xpharmacology |
650 | 0 | 4 |
_aWnt Proteins _xmetabolism |
700 | 1 | _aChu, Shaoyou | |
700 | 1 | _aWillard, Francis S | |
700 | 1 | _aCox, Karen L | |
700 | 1 | _aSells Galvin, Rachelle J | |
700 | 1 | _aPeery, Robert B | |
700 | 1 | _aOliver, Sarah E | |
700 | 1 | _aOler, Jennifer | |
700 | 1 | _aMeredith, Tamika D | |
700 | 1 | _aHeidler, Steven A | |
700 | 1 | _aGough, Wendy H | |
700 | 1 | _aHusain, Saba | |
700 | 1 | _aPalkowitz, Alan D | |
700 | 1 | _aMoxham, Christopher M | |
773 | 0 |
_tJournal of biomolecular screening _gvol. 16 _gno. 6 _gp. 588-602 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1087057111405379 _zAvailable from publisher's website |
999 |
_c20786675 _d20786675 |